Abstract
The acquired immune deficiency syndrome is caused by the human immunodeficiency virus (HIV) infection that causes immune system deterioration along with opportunistic infections. Lung diseases are common in children with HIV, especially recurrent infections that tend to present with fever, respiratory symptoms, increased work of breathing, and rapid progression, in contrast with noninfectious diseases that present with slow starting respiratory symptoms and have a wide range of clinical presentations. Bacterial pneumonia is the most frequent infectious entity in all stages of the disease, but its incidence has improved with highly active antiretroviral therapy (HAART) and immunizations. Tuberculosis has increased as a primary infection, but is poorly controlled, and may progress to systemic dissemination and development of extrapulmonary forms. Viral pneumonia has the same incidence as in normal children but tends to be severe with prolonged virus excretion. Cytomegalovirus is among the opportunistic agents that most commonly infect patients with acquired immune deficiency syndrome, especially those with severe immunosuppression. Pneumocystis jirovecii is the most common cause of atypical pneumonia in HIV-positive children; it can progress quickly with no treatment, even leading to respiratory failure. Chronic multifactorial lung disease used to be frequent in children, especially before HAART was introduced. Lymphocytic interstitial pneumonia used to be the most common of these entities. Some neoplasia may arise in the lung, or spread to it, such as non-Hodgkin lymphoma, Kaposi’s sarcoma, leiomyosarcoma, and Hodgkin’s lymphoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Sources
Centers for Disease Control and Prevention. Revised surveillance case definition for HIV infection-United States, 2014. MMWR. 2014;63(RR-3):1–10.
CDC. Guidelines for the use of antiretroviral agents in pediatric HIV infection 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 1994;43(RR-12):1–10.
CDC. Guidelines for prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. MMWR. 2013;62(44):889. http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf
Coinfección TB-VIH. Guía clínica, versión actualizada 2010. Washington DC: Organización Panamericana de la Salud (OPS); 2010.
Dankner W, Lindsey J, Levin M, Pediatric AIDS Clinical Trials Group Protocol Teams. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before HAART. Pediatr Infect Dis J. 2001;20(1):40–8.
Graham SM. Non-tuberculosis opportunistic infections and other lung diseases in HIV-infected infants and children [State of the Art]. Int J Tuberc Lung Dis. 2005;9(6):592–602.
Kilborn T, Zampoli M. Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children. Pediatr Radiol. 2009;39(6):569–74.
Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, et al. Rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis. Pediatrics. 2005;115(4):488–94.
Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. http://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatric-guidelines.pdf. Accessed on July 15th of 2015; table 7, page F-9.
Peña A, Larrañaga C, Luchsinger V, Villarroel J, Chávez A, Wu E y Comité Nacional de SIDA Pediátrico, Sociedad Chilena de Pediatría. Enfermedad por citomegalovirus (CMV) en niños chilenos infectados por el virus de la inmunodeficiencia humana (VIH). Rev Chil Infectol. 2007;24(6):477–84.
Theron S, Andronikou S, George R, du Plessis J, Goussard P, Hayes M, Mapukata A, Gie R. Non-infective lung disease in HIV-positive children. Pediatr Radiol. 2009;39(6):555–64.
UNAIDS. The Gap report. Acceso 24 de octubre de 2014 http://www.unaids.org/en/resources/campaigns/2014/2014gapreport/gapreport.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Peña Donati, A., Laufer, M. (2020). Acquired Immune Deficiency Syndrome. In: Bertrand, P., Sánchez, I. (eds) Pediatric Respiratory Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-26961-6_51
Download citation
DOI: https://doi.org/10.1007/978-3-030-26961-6_51
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26960-9
Online ISBN: 978-3-030-26961-6
eBook Packages: MedicineMedicine (R0)